Prior to 2008, components such as collagen and matrix in biomaterial research were primarily addressed in terms of their structural properties and biocompatibility. During this period, collagen was especially evaluated in the context of osteogenic applications and cellular responses
14. However, after 2008, there has been a notable shift toward therapeutic applications in collagen-based biomaterial research. Notably, collagens from marine sources (like fish skin, jellyfish, and sponges) have become more popular because they cause fewer immune reactions, are more sustainable, and offer ethical benefits
15,16. This evolution marks a significant advancement toward clinical applications in biomaterials research, with marine-derived collagens offering promising new opportunities in wound healing and regenerative therapies due to their sustainability and biocompatibility advantages. Our findings are consistent with the growing interest in marine-derived collagen reported in recent biomaterials and wound-healing reviews; accordingly, we discuss marine-derived collagens as an emerging, qualitative sub-trend rather than as a primary driver of the LDA topics
17-19.
In support of this, the LDA analysis revealed the co-occurrence of the term ?collagen? with concepts such as "therapeutic" and "regenerative," reinforcing the thematic transition observed in the field. In particular, the theme labeled as ?Collagen-Matrix Based Regeneration,? where collagen is prominently represented, highlights the therapeutic use of collagen-based biomaterials. Within this theme, collagen-based biomaterials are prominently represented; marine-derived collagens are therefore discussed here as a literature-supported sub-trend within the broader collagen landscape rather than as a distinct LDA-driven topic16,20. Furthermore, these biomaterials exhibit therapeutic potential in advanced applications, including controlled release systems and the design of biocompatible scaffolds16,21. Marine-sourced biomaterials may offer practical advantages (e.g., acceptability and supply sustainability) and are increasingly discussed in recent reviews; however, in our corpus they remained a secondary signal and were not a dominant driver of the LDA topics. Therefore, we frame marine-derived collagen as an emerging, literature-supported sub-trend that warrants targeted future work (e.g., standardized extraction/quality control and long-term in vivo safety studies) before stronger corpus-level claims can be made.
Expanding on the broader thematic trends, the findings also reveal distinct differences in biomaterials research before and after 2008. Studies prior to 2008 primarily focused on structural parameters, particularly surface properties and controlled drug release. The theme ?Surface Properties-Controlled Drug Release? was dominant, representing 34.8% of that period's content. This focus reflected efforts to understand how physicochemical properties of biomaterials influenced cellular behavior. However, after 2008, a clear transition toward functional biomaterials became evident. During this newer period, themes such as ?Mechanical Properties?Structural Functionality? (27.3%) and ?Functional Hydrogels-Tissue Engineering? (25.1%) emerged, suggesting that biomaterials were increasingly being designed to perform biological roles, not just structural support. Among these, nanofiber-based wound dressings (particularly those produced via electrospinning) have shown promise in enhancing wound healing and minimizing scar formation22. Functional hydrogels have similarly become central, given their high-water content, biocompatibility, and versatility in regenerative medicine. The expanding use of such hydrogels, especially in personalized disease modeling, reflects a broader trend toward more active and regenerative roles for biomaterials23.
This progression underscores a paradigmatic shift-from passive, structural materials to dynamic, bioactive systems. Our findings are consistent with this evolution, as reflected by the post-2008 prominence of topics centered on functional hydrogels, infection control, and regenerative tissue engineering in the LDA output. These advances pave the way for disease-specific, patient-tailored therapies with enhanced clinical efficacy, particularly for complex wound types such as diabetic foot ulcers, burns, and postoperative lesions.
As this thematic transformation unfolds, it is bringing biomaterials research closer to real-world clinical application. Innovations are now targeting specific medical challenges, including diabetic wounds, antimicrobial resistance, and host biocompatibility. Nanofiber and hydrogel-based biomaterials, in particular, are well positioned to meet these demands24. Moreover, while wound healing did not appear as a clearly defined thematic category prior to 2008, the emergence of the ?Infection Control?Wound Healing? theme post-2008 (though relatively lower in prevalence) indicates a growing clinical relevance. This evolution suggests that earlier studies were largely confined to laboratory environments, focusing on in vitro experiments. Supporting this, literature from the early 2000s often concentrated on cellular responses to material surfaces rather than holistic biological contexts25,26.
Clinically, the post-2008 emergence of ?Infection Control?Wound Healing? is plausibly linked to the rising emphasis on antimicrobial resistance and on local bioburden management in both chronic and postoperative wounds. This has accelerated interest in antimicrobial dressings and multifunctional biomaterials that combine barrier function with active antimicrobial or antibiofilm mechanisms. Examples include silver- and nanoparticle-containing systems, honey-based dressings and hydrogels, and plant-derived bioactives incorporated into films/hydrogels for antioxidant and antimicrobial effects. In this context, the infection-control signal captured by topic modeling can be interpreted as reflecting a broader convergence of biomaterials engineering with antimicrobial stewardship needs27-29.
Importantly, part of this translational trajectory is reflected in veterinary wound management, where biomaterial dressings are frequently evaluated in clinically realistic contexts (contaminated wounds, large tissue loss, and challenging anatomic sites). In companion animals, biomaterial-based dressings and biologic grafts have been reported to support healing after wide excisions and complex soft-tissue defects. In equine surgery, distal limb wounds represent a well-known clinical challenge characterized by delayed granulation and higher complication risk, making them a relevant model for testing hydrogel- and antimicrobial-dressing strategies. We therefore interpret the veterinary-oriented subset as complementary evidence that helps bridge laboratory innovation with real-world wound environments30-32.
From a field-utility perspective, veterinary patients provide clinically realistic wound environments (contamination, motion, distal limb ischemia, large tissue loss) where biomaterial dressings are stress-tested under conditions similar to complex human wounds. Marine-origin dressings are particularly relevant here: acellular fish-skin xenografts and marine collagen matrices have been increasingly reported in companion animal soft-tissue reconstruction and in equine distal limb wounds, which are known for delayed granulation and higher complication rates. These applications strengthen the translational interpretation of the post-2008 ?infection control? and ?functional hydrogel? themes by illustrating where and why clinicians adopt bioactive scaffolds and antimicrobial dressings outside controlled laboratory settings33,34.
In contrast, the post-2008 period has witnessed increasing attention to in vivo relevance and translational potential. For example, the emergence of functional wound healing themes corresponds with rising interest in direct biomaterial-tissue interactions. This shift has opened doors to translational research, leading to more clinically grounded strategies (35, 36). Notably, the increase in in vivo research reflects a demand for biomaterials that perform reliably in dynamic, real-world environments. Developments in dual-function biomaterials (those combining antimicrobial and regenerative capabilities) have played a role in improving success rates in vivo37,38.
Beyond simple term-frequency shifts, the post-2008 vocabulary increasingly reflects engineering-driven formulation strategies. The rise of ?-based? is best interpreted not as an informative keyword per se, but as a linguistic marker of more specific material descriptors (e.g., collagen-based, hydrogel-based). In parallel, the field has moved toward composite and hybrid scaffolds (particularly fiber-hydrogel and nanofiber-enhanced hydrogel composites) that aim to combine ECM-mimicking architecture with tunable mechanics, moisture management, and controlled delivery of therapeutics. This composite design paradigm provides a more mechanistically meaningful interpretation of the lexical shift than the standalone token ?based?39-41.
In parallel with these developments, the literature increasingly explores marine-derived collagens as alternatives to mammalian sources, motivated by biocompatibility, sustainability, and ethical considerations. Traditionally, collagen is derived from mammals like pigs, cattle, and rodents. However, concerns related to zoonotic transmission and religious acceptability have prompted increased exploration of marine organisms (including fish, jellyfish, and sponges) as safer alternatives21,42. Marine-sourced collagens, gelatins, and chitosan offer compelling advantages, including lower immunogenicity, ethical acceptability, and potential for sustainable production15,43-45.
A further driver of the shift toward non-mammalian collagen sources is biosafety. Mammalian-derived collagens (bovine/porcine) have historically raised concerns regarding zoonotic contamination and, although tightly regulated, a theoretical risk related to transmissible spongiform encephalopathies (e.g., prion/BSE) is frequently cited in the biomaterials safety literature. Marine-derived collagen avoids several mammalian-specific pathogen concerns and can offer advantages in acceptability and supply sustainability; nevertheless, marine sources introduce their own safety-control requirements (e.g., heavy metals, endotoxin burden, batch variability), making standardized extraction and quality-control pipelines essential for translational adoption46,47.
These considerations are presented here as contextual evidence from the broader literature rather than as a direct output of our LDA results. While marine-derived materials are discussed in reviews in relation to sustainability, acceptability, and biosafety, our corpus-level signal remained low (i.e., a secondary, qualitative signal rather than a dominant topic driver). Accordingly, we interpret ethical/ecological arguments and quality-control challenges (batch variability, interspecies differences, potential contaminants such as heavy metals and endotoxin, and standardization needs) as literature-informed translational considerations that warrant targeted future work, rather than as findings emerging from the topic model itself.
A methodological limitation relates to the search query. By using ?biomaterial? AND ?wound healing? as required terms, the corpus may undercapture studies that primarily use specific material family labels (e.g., hydrogel, scaffold, nanofiber, electrospun mat) without explicitly using the umbrella term ?biomaterial?. While this choice improved precision and reproducibility, it may reduce recall. Future work could incorporate an expanded query set (e.g., adding major material-family keywords) and compare topic stability via sensitivity analyses.
Additional limitations include reliance on a single database (WoS Core Collection), English-language records, and abstract-only modeling, which may omit full-text nuance and non-indexed literature. In addition, the pre-2008 and post-2008 subsets were markedly unequal in size (297 vs 4,019), which may influence estimated topic prevalence; therefore, temporal contrasts are reported descriptively. As an unsupervised approach, LDA provides thematic structure rather than causal inference; therefore, findings should be interpreted as descriptive trends.
When examined comprehensively, marine-sourced biomaterials clearly present compelling advantages. Their inherent antibacterial properties, biodegradability, environmental sustainability, and compatibility with cellular systems make them particularly well-suited for next-generation wound care and regenerative solutions48. These considerations are discussed here as literature-based translational context; however, consistent with the low corpus-level frequency of marinerelated terms, marine collagens should be interpreted as an emerging, literature-supported sub-trend rather than a dominant LDA-driven finding.
This study provides a comprehensive overview of the evolving research landscape in wound healing and highlights the growing importance of marine-derived collagen as a sustainable, biocompatible, and immunologically safe alternative to traditional biomaterials. Topic modeling of over two decades of literature revealed a clear thematic shift from structure- focused and in vitro studies toward functionality-driven applications such as controlled drug delivery, infection prevention, and tissue regeneration. Based on these trends, future research is expected to emphasize the development of biomaterials with enhanced mechanical and functional performance, integrated into smart systems that actively support the healing process. Marine collagen-based hydrogels and scaffolds, when combined with emerging technologies like 3D bioprinting and nanotechnology, may offer promising pathways toward personalized and translational wound therapies.